Facet Biotech to Cut 80 Jobs; Narrows Focus on Oncology

Jan 7 (Reuters) - Facet Biotech Corp (FACT.O), which was spun-off from PDL BioPharma Inc (PDLI.O) in December last year, said it would cut about 80 jobs as it tries to reduce costs and narrow its focus on oncology drug candidates.
MORE ON THIS TOPIC